Metraipolis › archive › dc_eb35c0af7942

A longitudinal multi-omic dataset of pediatric cystic fibrosis patients receiving lumacaftor/ivacaftor therapy: clinical, microbiome, inflammatory and… — Europe PMC PMID:42825108

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42825108
DOI
10.1016/j.dib.2026.113237
License (as archived)
solo-consultazione
Archived
2026-10-07T12:29:52.683Z
SHA-256 of the archived text
0a0068f52f82ae9cd305828da4aa67e9c1a69f2500c39472900ce9e90a522895
Stable URL of this page
https://metraipolis.com/documento/dc_eb35c0af7942

How to cite

A longitudinal multi-omic dataset of pediatric cystic fibrosis patients receiving lumacaftor/ivacaftor therapy: clinical, microbiome, inflammatory and… — Europe PMC PMID:42825108 — Europe PMC (en), https://europepmc.org/article/MED/42825108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb35c0af7942 (Metraipolis archive dc_eb35c0af7942, sha256 0a0068f52f82ae9cd305828da4aa67e9c1a69f2500c39472900ce9e90a522895)
BibTeX
@misc{dceb35c0af7942,
  title = {A longitudinal multi-omic dataset of pediatric cystic fibrosis patients receiving lumacaftor/ivacaftor therapy: clinical, microbiome, inflammatory and… — Europe PMC PMID:42825108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42825108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb35c0af7942; sha256 0a0068f52f82ae9cd305828da4aa67e9c1a69f2500c39472900ce9e90a522895},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42825108. Agents can read the archived copy with the MCP tool read_document.